|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.310 USD | -2.96% |
|
-1.50% | -28.02% |
| 07-22 | Alzamend Neuro, Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 | CI |
| 07-21 | Alzamend Neuro, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 1.37 | 2.18 | 1.63 |
| Spread/Res. | -4.38% | -39.91% | -19.63% |
| Spread/Supp. | +16.96% | +52.77% | +52.77% |
| Support | 1.12 | 0.8575 | 0.8575 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALZN Stock
- Charts Alzamend Neuro, Inc.
Select your edition
All financial news and data tailored to specific country editions
